Provided by Tiger Trade Technology Pte. Ltd.

VistaGen Therapeutics

0.2810
-0.0016-0.57%
Post-market: 0.2787-0.0023-0.82%19:55 EDT
Volume:1.25M
Turnover:354.55K
Market Cap:12.47M
PE:-0.17
High:0.2999
Open:0.2837
Low:0.2778
Close:0.2826
52wk High:5.14
52wk Low:0.1980
Shares:44.38M
Float Shares:41.42M
Volume Ratio:0.35
T/O Rate:3.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6559
EPS(LYR):-1.8303
ROE:-166.46%
ROA:-83.21%
PB:0.51
PE(LYR):-0.15

Loading ...

May 27, 2021

Major Issues Report

8-K - Current report
May 14, 2021

Major Issues Report

8-K - Current report
May 04, 2021

Major Issues Report

8-K - Current report
Apr 29, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 27, 2021

Major Issues Report

8-K - Current report
Apr 26, 2021

Major Issues Report

8-K - Current report
Mar 23, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 22, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 05, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Major Issues Report

8-K - Current report
Feb 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 02, 2021

Major Issues Report

8-K - Current report
Jan 22, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2021

Major Issues Report

8-K - Current report
Jan 04, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Dec 22, 2020

Major Issues Report

8-K - Current report
Dec 18, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses